Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
Volume 15 Issue 6
Nov.  2024
Turn off MathJax
Article Contents

WU Haoheng, LIU Zhu, SHO Jia, MA Xiang, LI Hong, TANG Yanqiong, CHI Xue, LI Juanjuan. Evaluation of the therapeutic effect of Bacillus subtilis on the intestinal tract of mice infected by Aeromonas veronii[J]. Journal of Tropical Biology, 2024, 15(6): 756-763. doi: 10.15886/j.cnki.rdswxb.20240112
Citation: WU Haoheng, LIU Zhu, SHO Jia, MA Xiang, LI Hong, TANG Yanqiong, CHI Xue, LI Juanjuan. Evaluation of the therapeutic effect of Bacillus subtilis on the intestinal tract of mice infected by Aeromonas veronii[J]. Journal of Tropical Biology, 2024, 15(6): 756-763. doi: 10.15886/j.cnki.rdswxb.20240112

Evaluation of the therapeutic effect of Bacillus subtilis on the intestinal tract of mice infected by Aeromonas veronii

doi: 10.15886/j.cnki.rdswxb.20240112
  • Received Date: 2024-06-29
  • Rev Recd Date: 2024-08-20
  • Infection of Aeromonas veroniiA. veronii), a kind of zoonotic multidrug-resistant bacteria, is mainly treated or prevented with antibiotics. However, the extensive use of antibiotics can lead to the emergence of new drug-resistant mutant strains. Bacillus subtilisB. subtilis), as a common probiotic, which can inhibit various species of pathogenic bacteria. The antibacterial ability of B. subtilis against A. veronii was detected and its therapeutic effect on A. veronii intestinal infection evaluated. Filter paper method showed that B. subtilis possessed an obvious inhibitory effect on A. veronii C4, and TEM showed that it caused the dilatation and damage of A. veronii C4 cells. In addition, B. subtilis reduced the intracellular cytotoxicity of A. veronii C4. In a mouse model with damaged intestinal barrier, B. subtilis showed higher efficiency than the clinical antibiotic on A.veronii C4 infections, contributing to their natural ability of intestinal barrier repair and the antibacterial ability against A. veronii C4. B.subtilis can thus be used as a biocontrol agent for the treatment of A. veronii infection,which is of great significance for curbing the development of drug-resistance.
  • [1] CHEN P L, LEE T F, WU C J, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry can accurately differentiate Aeromonas dhakensis from A.hydrophila, A. caviae, and A. veronii[J]. Journal of Clinical Microbiology, 2014, 52(7):2625-2628.
    [2] SKWOR T, SHINKO J, AUGUSTYNIAK A, et al. Aeromonas hydrophila and Aeromonas veronii predominate among potentially pathogenic ciprofloxacin-and tetracyclineresistant Aeromonas isolates from Lake Erie[J]. Applied and Environmental Microbiology, 2014, 80(3):841-848.
    [3] XIUCAI H, XIAOXUE L, AIJUN L, et al. Characterization and pathology of Aeromonas veronii biovar sobria from diseased sheatfish Silurus glanis in China[J]. Israeli Journal of Aquaculture-Bamidgeh, 2019, 71:26-38.
    [4] CHUANG H C, HO Y H, LAY C J, et al. Different clinical characteristics among Aeromonas hydrophila, Aeromonas veronii biovar sobria and Aeromonas caviae monomicrobial bacteremia[J]. Journal of Korean Medical Science, 2011,26(11):1415-1420.
    [5] WOO S J, KIM M S, JEONG M G, et al. Establishment of epidemiological cut-off values and the distribution of resistance genes in Aeromonas hydrophila and Aeromonas veronii isolated from aquatic animals[J]. Antibiotics, 2022,11(3):343.
    [6] 王祖成,马香,李宏,等.维氏气单胞菌flrB基因敲除株构建及其生物特性鉴定[J].热带生物学报, 2021, 12(2):161-166.
    [7] BERMÚDEZ-HUMARÁN L G, SALINAS E, ORTIZ G G,et al. From probiotics to psychobiotics:live beneficial bacteria which act on the brain-gut axis[J]. Nutrients, 2019, 11(4):890.
    [8] KERNBAUER E, DING Y, CADWELL K. An enteric virus can replace the beneficial function of commensal bacteria[J]. Nature, 2014, 516:94-98.
    [9] ZHANG C, HUANG J, ZHANG J, et al. Engineered Bacillus subtilis biofilms as living glues[J]. Materials Today,2019, 28:40-48.
    [10] RWUBUZIZI R, KIM H, HOLZAPFEL W H, et al. Beneficial, safety, and antioxidant properties of lactic acid bacteria:a next step in their evaluation as potential probiotics[J]. Heliyon, 2023, 9(4):e15610.
    [11] KANG S Y, POKHREL A, BRATSCH S, et al. Engineering Bacillus subtilis for the formation of a durable living biocomposite material[J]. Nature Communications, 2021,12:7133.
    [12] DUNLAP C A, BOWMAN M J, ZEIGLER D R. Promotion of Bacillus subtilis subsp. inaquosorum, Bacillus subtilis subsp. spizizenii and Bacillus subtilis subsp. stercoris to species status[J]. Antonie Van Leeuwenhoek, 2020,113(1):1-12.
    [13] WANG G, GUO Z, ZHANG X, et al. Heterologous expression of pediocin/papA in Bacillus subtilis[J]. Microbial Cell Factories, 2022, 21(1):104.
    [14] LIU Y, SU A, TIAN R, et al. Developing rapid growing Bacillus subtilis for improved biochemical and recombinant protein production[J]. Metabolic Engineering Communications, 2020,11:e00141.
    [15] MCKENNEY P T, DRIKS A, EICHENBERGER P. The Bacillus subtilis endospore:assembly and functions of the multilayered coat[J]. Nature Reviews Microbiology, 2013,11:33-44.
    [16] EREGA A, STEFANIC P, DOGSA I, et al. Bacillaene mediates the inhibitory effect of Bacillus subtilis on Campylobacter jejuni biofilms[J]. Applied and Environmental Microbiology, 2021, 87(12):e0295520.
    [17] 齐涵,王淑芬,任秋生,等.枯草芽孢杆菌BS224菌制剂防治烧伤的临床研究[J].中国微生态学杂志, 1997,9(3):20-22.
    [18] 简钰乘.薏苡附子败将散对DSS诱导小鼠溃疡性结肠炎的作用机制研究[D].南昌:江西中医药大学,2023.
    [19] 孙世涛,周永学.周永学教授治疗溃疡性结肠炎经验[J].四川中医, 2022, 40(12):7-10.
    [20] 马恒辉,周晓军. HE染色常见问题与对策[J].临床与实验病理学杂志, 2008, 24(4):478-481.
    [21] 范小莉,胥维勇,杨群,等. HE染色不良的分析与应对方法[J].临床与实验病理学杂志, 2014, 30(7):805-807.
    [22] 王帅,高圣风,高学文,等.枯草芽孢杆菌脂肽类抗生素发酵和提取条件[J].中国生物防治, 2007, 23(4):342-347.
    [23] 王勤.枯草芽孢杆菌在家禽养殖的应用与展望[J].家禽科学, 2019(10):48-52.
    [24] JAYARAMAN V, LEE D J, ELAD N, et al. A counterenzyme complex regulates glutamate metabolism in Bacillus subtilis[J]. Nature Chemical Biology, 2022, 18:161-170.
    [25] HOU W, LI J, CAO Z, et al. Decorating bacteria with a therapeutic nanocoating for synergistically enhanced biotherapy[J]. Small, 2021, 17(37):e2101810.
    [26] SIONEK B, SZYDŁOWSKA A, ZIELIŃSKA D, et al.Beneficial bacteria isolated from food in relation to the next generation of probiotics[J]. Microorganisms, 2023,11(7):1714.
    [27] Dunlap C A, Bowman M J, Zeigler D R. Promotion of Bacillus subtilis subsp. inaquosorum, Bacillus subtilis subsp. spizizenii and Bacillus subtilis subsp. stercoris to species status[J]. Antonie van Leeuwenhoek, 2020,113(1):1-12.
    [28] GUO S, MU L, SUN S, et al. Concurrence of microplastics and heat waves reduces rice yields and disturbs the agroecosystem nitrogen cycle[J]. Journal of Hazardous Materials, 2023, 452:131340.
    [29] BRAAT N, KOSTER M C, WÖSTEN H A B. Beneficial interactions between bacteria and edible mushrooms[J].Fungal Biology Reviews, 2022, 39:60-72.
    [30] FEDDERSEN H, WÜRTHNER L, FREY E, et al.Dynamics of the Bacillus subtilis Min system[J]. mBio,2021, 12(2):e00296-e00221.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article views(24) PDF downloads(0) Cited by()

Proportional views
Related

Evaluation of the therapeutic effect of Bacillus subtilis on the intestinal tract of mice infected by Aeromonas veronii

doi: 10.15886/j.cnki.rdswxb.20240112

Abstract: Infection of Aeromonas veroniiA. veronii), a kind of zoonotic multidrug-resistant bacteria, is mainly treated or prevented with antibiotics. However, the extensive use of antibiotics can lead to the emergence of new drug-resistant mutant strains. Bacillus subtilisB. subtilis), as a common probiotic, which can inhibit various species of pathogenic bacteria. The antibacterial ability of B. subtilis against A. veronii was detected and its therapeutic effect on A. veronii intestinal infection evaluated. Filter paper method showed that B. subtilis possessed an obvious inhibitory effect on A. veronii C4, and TEM showed that it caused the dilatation and damage of A. veronii C4 cells. In addition, B. subtilis reduced the intracellular cytotoxicity of A. veronii C4. In a mouse model with damaged intestinal barrier, B. subtilis showed higher efficiency than the clinical antibiotic on A.veronii C4 infections, contributing to their natural ability of intestinal barrier repair and the antibacterial ability against A. veronii C4. B.subtilis can thus be used as a biocontrol agent for the treatment of A. veronii infection,which is of great significance for curbing the development of drug-resistance.

WU Haoheng, LIU Zhu, SHO Jia, MA Xiang, LI Hong, TANG Yanqiong, CHI Xue, LI Juanjuan. Evaluation of the therapeutic effect of Bacillus subtilis on the intestinal tract of mice infected by Aeromonas veronii[J]. Journal of Tropical Biology, 2024, 15(6): 756-763. doi: 10.15886/j.cnki.rdswxb.20240112
Citation: WU Haoheng, LIU Zhu, SHO Jia, MA Xiang, LI Hong, TANG Yanqiong, CHI Xue, LI Juanjuan. Evaluation of the therapeutic effect of Bacillus subtilis on the intestinal tract of mice infected by Aeromonas veronii[J]. Journal of Tropical Biology, 2024, 15(6): 756-763. doi: 10.15886/j.cnki.rdswxb.20240112
Reference (30)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return